Volix R 0.3/1MG Tab

Composition

Repaglinide (1mg) + Voglibose (0.3mg)

Uses of Volix R 0.3/1MG Tab

Type 2 diabetes mellitus (as add-on to diet and exercise) to control post-meal (postprandial) blood sugar; used when single therapy is insufficient.

• •Reduces post-meal blood sugar spikes
• •Improves overall glycaemic control as add-on therapy
• •Flexible mealtime dosing
• •May help lower HbA1c when combined with diet and exercise

How it works

Voglibose is an alpha-glucosidase inhibitor that delays carbohydrate digestion and glucose absorption in the intestine, reducing post-meal glucose spikes. Repaglinide is a meglitinide that stimulates pancreatic insulin release by closing ATP-sensitive potassium channels in beta cells, mainly lowering postprandial glucose.

Directions for use

Oral tablet. Take as prescribed, typically just before meals (0–30 minutes before); if you skip a meal, skip the dose to reduce hypoglycaemia risk. Follow diet/exercise plan; monitor blood glucose regularly.

Side effects

Common side effects of Volix R 0.3/1MG Tab may include:

• •Hypoglycaemia
• •abdominal pain
• •flatulence
• •diarrhoea
• •nausea
• •headache